Cite
APA Citation
Link, H., Illerhaus, G., Martens, U. M., Salar, A., Depenbusch, R., Kohler, A., Engelhardt, M. M., Mahlmann, S., Zaiss, M., Lammerich, A., Bias, P., & Buchner, A. (n.d.). 1696PA randomized, open-label, non-inferiority study comparing the efficacy and safety of lipegfilgrastim versus pegfilgrastim in elderly patients with aggressive B-cell non-Hodgkin lymphomas (B-NHL): AVOID neutropenia. Annals of oncology, 29, . http://access.bl.uk/ark:/81055/vdc_100095502596.0x000031